Skip to content

GR Médical

Active
Private limited companyfounded 2023active for 2 yearsRue du Pont(AMA) 19, 4540 Amay, BelgiumKBO/BCE: BE 1001.909.139
Summary

GR Médical has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €232,553 and a net result of €114,044. Its solvency ranks better than 26% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
GR MédicalActiveChecked score 93/100
Risk analysis ReportCompare

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€751,812total assets 2025
Staff
1.8 FTE
Equity
€232,553
Profit
€114,044
Turnover not published (micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 106 days early
Why 93raises riskFounded in 2023lowers riskSector: Human health activities (NACE 86)Size: total assets €751,812Figures for financial year 2025 (filed 16-04-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 46% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 56+11
equity 30.9% of total assets
Liquidity 54-16
short-term debt 30.3% · cash 13.8%
Profitability 88-2
return on assets 15.2%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 12-2024: 0.3% 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.4%▲ +0.1 percentage points vs 05-2025highest value 07-2025: < 0.1%▼ -0.4 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €21,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity insufficient (current ratio 0.54, compared with 1.36 in 2024, below 1; short-term debt: 30.3% and cash: 13.8% of total assets), and 69.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 27% on solvency, 29% on liquidity, 41% on profitability and 89% on growth.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €751,812
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 16-04-2026)
NBB · annual accounts
raises risk · Founded in 2023
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-04-2026, 106 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
106 days early
2024
36 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 71 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
26-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Equity above €200,000equity €232,553 ▲96.2%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Equity rose in 2025from €118,509 to €232,553 ▲ 96.2% View
  • Among the largest 15% on gross marginsector median €112,974 · 20,616 companies €302,508 View
  • Board2 directors in office 2 View

By topic

Financials

Financial year
2025
Total assets
€751,812
Profit
€114,044
Solvency
30.9%
Total assets▲ 28.8%
Net result
20242025
Go to Financials

Board & ownership

Board
2 members
  • Graulich EmmanuelDirector
  • RUWET Elisabeth Marie Brigitte MichèleDirector
Go to Board & ownership

Timeline

Events
4
Since
2023
Next accounts
by 31-07-2027
  1. 07-11-2023Incorporation
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
03-11-2023
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
31
Purpose
“L’exercice de la médecine par le ou les actionnaires qui la composent,lesquels sont…” (deed in French)
Statutory auditor
No statutory auditor
Go to Articles of association

Key facts about GR Médical

What is the company number of GR Médical?
1001.909.139. In Belgium the VAT number is the company number with BE in front: BE 1001.909.139.
Where is GR Médical based?
The registered office is at Rue du Pont(AMA) 19, 4540 Amay.Company details
What does GR Médical do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of GR Médical?
Private limited company (BV).
When was GR Médical founded?
On 03-11-2023.
Is GR Médical still active?
Yes, GR Médical is an active enterprise in the KBO register.
How many employees does GR Médical have?
On average 1.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of GR Médical?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is GR Médical profitable?
In financial year 2025, GR Médical made a profit of €114,044.
Where can I find the annual accounts of GR Médical?
GR Médical filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of GR Médical due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to GR Médical

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure